Krasner, Carolyn
eCommons Login: CNK3
first name: Carolyn
last name: Krasner
coauthor of: Penson, Richard
coauthor of: Matulonis, Ursula
coauthor of: Campos, Susana
coauthor of: Konstantinopoulos, Panagiotis
coauthor of: Horowitz, Neil
full name: Carolyn Nancy Krasner, M.D.
has faculty rank: Instructor
has network: selected publications
has network: research areas
has network: coauthor of
has network: similar to
latitude: 42.36241700000000
longitude: -71.06893700000000
Person ID: 80873
person in primary position: Instructor in Medicine
physical neighbor: Barbie, David
physical neighbor: Bychkovsky, Brittany
physical neighbor: Iyasere, Christiana
physical neighbor: Murakami, Mark
physical neighbor: Shaw, Alice
similar to: Matulonis, Ursula
similar to: Konstantinopoulos, Panagiotis
similar to: Oliva, Esther
similar to: Tolaney, Sara
similar to: Richardson, Paul
type: Agent
type: Person
selected publications: Authorship 1794140
selected publications: Authorship 1825055
selected publications: Authorship 1752791
selected publications: Authorship 1740135
selected publications: Authorship 1659054
selected publications: Authorship 1630316
selected publications: Authorship 1563795
selected publications: Authorship 1521552
selected publications: Authorship 1500275
selected publications: Authorship 1500726
selected publications: Authorship 1463029
selected publications: Authorship 1429608
selected publications: Authorship 1373558
selected publications: Authorship 1337812
selected publications: Authorship 1334136
selected publications: Authorship 1317341
selected publications: Authorship 1276495
selected publications: Authorship 1186043
selected publications: Authorship 1131956
selected publications: Authorship 1139598
selected publications: Authorship 949874
selected publications: Authorship 925933
selected publications: Authorship 875718
selected publications: Authorship 819342
selected publications: Authorship 799639
selected publications: Authorship 765434
selected publications: Authorship 714899
selected publications: Authorship 675063
selected publications: Authorship 664315
selected publications: Authorship 250157
selected publications: Authorship 399957
selected publications: Authorship 224486
selected publications: Authorship 311448
selected publications: Authorship 234178
selected publications: Authorship 926250
selected publications: Authorship 944777
selected publications: Authorship 945638
selected publications: Authorship 946033
selected publications: Authorship 1171
selected publications: Authorship 229002
selected publications: Authorship 414993
selected publications: Authorship 15940
selected publications: Authorship 263833
selected publications: Authorship 234465
selected publications: Authorship 303829
selected publications: Authorship 941836
selected publications: Authorship 943784
selected publications: Authorship 361068
selected publications: Authorship 548582

eCommons Login
tag name: catalyst:eCommonsLogin
type: DatatypeProperty

coauthor of
tag name: prns:coAuthorOf
type: ObjectProperty

Faculty Rank
type: Class

full name
tag name: prns:fullName
type: DatatypeProperty

author list
tag name: prns:hasAuthorList
type: DatatypeProperty

has faculty rank
tag name: prns:hasFacultyRank
type: ObjectProperty

has network
tag name: prns:hasNetwork
type: ObjectProperty

published in
tag name: prns:hasPublicationVenue
type: DatatypeProperty

information resource reference
tag name: prns:informationResourceReference
type: DatatypeProperty

is primary position
tag name: prns:isPrimaryPosition
type: DatatypeProperty

latitude
tag name: prns:latitude
type: DatatypeProperty

longitude
tag name: prns:longitude
type: DatatypeProperty

maximum weight
tag name: prns:maxWeight
type: DatatypeProperty

journal title abbreviation
tag name: prns:medlineTA
type: DatatypeProperty

MeSH DescriptorUI
tag name: prns:meshDescriptorUI
type: DatatypeProperty

MeSH semantic group name
tag name: prns:meshSemanticGroupName
type: DatatypeProperty

minimum weight
tag name: prns:minWeight
type: DatatypeProperty

number of authors
tag name: prns:numberOfAuthors
type: DatatypeProperty

number of connections
tag name: prns:numberOfConnections
type: DatatypeProperty

number of publications
tag name: prns:numberOfPublications
type: DatatypeProperty

Person ID
tag name: prns:personId
type: DatatypeProperty

person in primary position
tag name: prns:personInPrimaryPosition
type: ObjectProperty

physical neighbor
tag name: prns:physicalNeighborOf
type: ObjectProperty

position in department
tag name: prns:positionInDepartment
type: ObjectProperty

position in division
tag name: prns:positionInDivision
type: ObjectProperty

predicate node
tag name: prns:predicateNode
type: ObjectProperty

publication date
tag name: prns:publicationDate
type: DatatypeProperty

similar to
tag name: prns:similarTo
type: ObjectProperty

sort order
tag name: prns:sortOrder
type: DatatypeProperty

uniqueness weight
tag name: prns:uniquenessWeight
type: DatatypeProperty

year
tag name: prns:year
type: DatatypeProperty

Academic Article
type: Class

Article
type: Class

Document
type: Class

PubMed Identifier
tag name: bibo:pmid
type: DatatypeProperty

Address
type: Class

address line 1
tag name: vivo:address1
type: DatatypeProperty

address line 2
tag name: vivo:address2
type: DatatypeProperty

address line 3
tag name: vivo:address3
type: DatatypeProperty

city
tag name: vivo:addressCity
type: DatatypeProperty
type: FunctionalProperty

postal code
tag name: vivo:addressPostalCode
type: DatatypeProperty
type: FunctionalProperty

state or province
tag name: vivo:addressState
type: DatatypeProperty
type: FunctionalProperty

selected publications
tag name: vivo:authorInAuthorship
type: ObjectProperty

author rank in publication
tag name: vivo:authorRank
type: DatatypeProperty
type: FunctionalProperty

Authorship
type: Class

Department
type: Class

Division
type: Class

research areas
tag name: vivo:hasResearchArea
type: ObjectProperty

HR job title
tag name: vivo:hrJobTitle
type: DatatypeProperty

Information Resource
type: Class

linked author
tag name: vivo:linkedAuthor
type: ObjectProperty

linked information resource
tag name: vivo:linkedInformationResource
type: ObjectProperty

mailing address
tag name: vivo:mailingAddress
type: ObjectProperty

middle name or initial
tag name: vivo:middleName
type: DatatypeProperty
type: FunctionalProperty

positions
tag name: vivo:personInPosition
type: ObjectProperty

phone
tag name: vivo:phoneNumber
type: DatatypeProperty

Position
type: Class

position in organization
tag name: vivo:positionInOrganization
type: ObjectProperty

preferred title
tag name: vivo:preferredTitle
type: DatatypeProperty
type: FunctionalProperty

predicate
tag name: rdf:predicate
type: ObjectProperty

type
tag name: rdf:type
type: ObjectProperty

label
tag name: rdfs:label
type: DatatypeProperty

Concept
type: Class

Agent
type: Class

first name
tag name: foaf:firstName
type: DatatypeProperty
type: FunctionalProperty

last name
tag name: foaf:lastName
type: DatatypeProperty
type: FunctionalProperty

Organization
type: Class

Person
type: Class

Zevalin: 90yttrium labeled anti-CD20 (ibritumomab tiuxetan), a new treatment for non-Hodgkin's lymphoma.
PubMed Identifier: 11762415
author list: Krasner C, Joyce RM
published in: Current pharmaceutical biotechnology
information resource reference: Zevalin: 90yttrium labeled anti-CD20 (ibritumomab tiuxetan), a new treatment for non-Hodgkin's lymphoma. Curr Pharm Biotechnol. 2001 Dec; 2(4):341-9.
journal title abbreviation: Curr Pharm Biotechnol
publication date: 2001-12-01T00:00:00
year: 2001
type: Academic Article
type: Article
type: Document
type: Information Resource

Low-molecular-weight heparin (dalteparin) in women with gynecologic malignancy.
PubMed Identifier: 15863537
author list: DeBernardo RL, Perkins RB, Littell RD, Krasner CN, Duska LR
published in: Obstetrics and gynecology
information resource reference: Low-molecular-weight heparin (dalteparin) in women with gynecologic malignancy. Obstet Gynecol. 2005 May; 105(5 Pt 1):1006-11.
journal title abbreviation: Obstet Gynecol
publication date: 2005-05-01T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

A phase II study of fixed dose rate gemcitabine in patients with relapsed müllerian tumors.
PubMed Identifier: 16343179
author list: Penson RT, Campos SM, Seiden MV, Krasner C, Fuller AF, Goodman A, Roche M, Willman A, Muzikansky A, Matulonis UA
published in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
information resource reference: A phase II study of fixed dose rate gemcitabine in patients with relapsed müllerian tumors. Int J Gynecol Cancer. 2005 Nov-Dec; 15(6):1035-41.
journal title abbreviation: Int J Gynecol Cancer
publication date: 2005-11-01T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management.
PubMed Identifier: 19501233
author list: Hesterberg PE, Banerji A, Oren E, Penson RT, Krasner CN, Seiden MV, Wong JT
published in: The Journal of allergy and clinical immunology
information resource reference: Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management. J Allergy Clin Immunol. 2009 Jun; 123(6):1262-7.e1.
journal title abbreviation: J Allergy Clin Immunol
publication date: 2009-06-01T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Phase I trial of liposomal doxorubicin and ZD1839 in patients with refractory gynecological malignancies or metastatic breast cancer.
PubMed Identifier: 20405155
author list: Campos SM, Berlin ST, Parker LM, Chen WY, Bunnell CA, Atkinson T, Lee J, Matulonis U, Hirsch MS, Harris L, Krasner CN
published in: International journal of clinical oncology
information resource reference: Phase I trial of liposomal doxorubicin and ZD1839 in patients with refractory gynecological malignancies or metastatic breast cancer. Int J Clin Oncol. 2010 Aug; 15(4):390-8.
journal title abbreviation: Int J Clin Oncol
publication date: 2010-04-20T00:00:00
year: 2010
type: Academic Article
type: Article
type: Document
type: Information Resource

Patterns of recurrence in advanced epithelial ovarian, fallopian tube and peritoneal cancers treated with intraperitoneal chemotherapy.
PubMed Identifier: 22659193
author list: Esselen KM, Rodriguez N, Growdon W, Krasner C, Horowitz NS, Campos S
published in: Gynecologic oncology
information resource reference: Patterns of recurrence in advanced epithelial ovarian, fallopian tube and peritoneal cancers treated with intraperitoneal chemotherapy. Gynecol Oncol. 2012 Oct; 127(1):51-4.
journal title abbreviation: Gynecol Oncol
publication date: 2012-05-30T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

Phase II study of carboplatin and pemetrexed for the treatment of platinum-sensitive recurrent ovarian cancer.
PubMed Identifier: 19001330
author list: Matulonis UA, Horowitz NS, Campos SM, Lee H, Lee J, Krasner CN, Berlin S, Roche MR, Duska LR, Pereira L, Kendall D, Penson RT
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Phase II study of carboplatin and pemetrexed for the treatment of platinum-sensitive recurrent ovarian cancer. J Clin Oncol. 2008 Dec 10; 26(35):5761-6.
journal title abbreviation: J Clin Oncol
publication date: 2008-11-10T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Management of women with newly diagnosed ovarian cancer.
PubMed Identifier: 19332244
author list: Krasner C, Duska L
published in: Seminars in oncology
information resource reference: Management of women with newly diagnosed ovarian cancer. Semin Oncol. 2009 Apr; 36(2):91-105.
journal title abbreviation: Semin Oncol
publication date: 2009-04-01T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

A phase II trial of weekly docetaxel in patients with platinum-resistant epithelial ovarian, primary peritoneal serous cancer, or fallopian tube cancer.
PubMed Identifier: 15581974
author list: Berkenblit A, Seiden MV, Matulonis UA, Penson RT, Krasner CN, Roche M, Mezzetti L, Atkinson T, Cannistra SA
published in: Gynecologic oncology
information resource reference: A phase II trial of weekly docetaxel in patients with platinum-resistant epithelial ovarian, primary peritoneal serous cancer, or fallopian tube cancer. Gynecol Oncol. 2004 Dec; 95(3):624-31.
journal title abbreviation: Gynecol Oncol
publication date: 2004-12-01T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

Phase II trial of GM-CSF in women with asymptomatic recurrent müllerian tumors.
PubMed Identifier: 19922985
author list: Roche MR, Rudd PJ, Krasner CN, Matulonis UA, Berlin ST, Lee H, Silver M, Tran CD, Seiden MV, Penson RT
published in: Gynecologic oncology
information resource reference: Phase II trial of GM-CSF in women with asymptomatic recurrent müllerian tumors. Gynecol Oncol. 2010 Feb; 116(2):168-72.
journal title abbreviation: Gynecol Oncol
publication date: 2009-11-18T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Trabectedin plus pegylated liposomal Doxorubicin in recurrent ovarian cancer.
PubMed Identifier: 20516432
author list: Monk BJ, Herzog TJ, Kaye SB, Krasner CN, Vermorken JB, Muggia FM, Pujade-Lauraine E, Lisyanskaya AS, Makhson AN, Rolski J, Gorbounova VA, Ghatage P, Bidzinski M, Shen K, Ngan HY, Vergote IB, Nam JH, Park YC, Lebedinsky CA, Poveda AM
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Trabectedin plus pegylated liposomal Doxorubicin in recurrent ovarian cancer. J Clin Oncol. 2010 Jul 01; 28(19):3107-14.
journal title abbreviation: J Clin Oncol
publication date: 2010-06-01T00:00:00
year: 2010
type: Academic Article
type: Article
type: Document
type: Information Resource

Trabectedin plus pegylated liposomal doxorubicin (PLD) versus PLD in recurrent ovarian cancer: overall survival analysis.
PubMed Identifier: 22541893
author list: Monk BJ, Herzog TJ, Kaye SB, Krasner CN, Vermorken JB, Muggia FM, Pujade-Lauraine E, Park YC, Parekh TV, Poveda AM
published in: European journal of cancer (Oxford, England : 1990)
information resource reference: Trabectedin plus pegylated liposomal doxorubicin (PLD) versus PLD in recurrent ovarian cancer: overall survival analysis. Eur J Cancer. 2012 Oct; 48(15):2361-8.
journal title abbreviation: Eur J Cancer
publication date: 2012-04-26T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

Three sequential chemotherapy doublets for the treatment of newly diagnosed advanced müllerian malignancies: the modified triple doublet regimen.
PubMed Identifier: 16806439
author list: Matulonis UA, Campos S, Krasner CN, Duska LR, Penson RT, Falke R, Roche M, Smith LM, Lee H, Seiden MV
published in: Gynecologic oncology
information resource reference: Three sequential chemotherapy doublets for the treatment of newly diagnosed advanced müllerian malignancies: the modified triple doublet regimen. Gynecol Oncol. 2006 Nov; 103(2):575-80.
journal title abbreviation: Gynecol Oncol
publication date: 2006-06-23T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

Extent of extracranial disease is a powerful predictor of survival in patients with brain metastases from gynecological cancer.
PubMed Identifier: 17587320
author list: Growdon WB, Lopez-Varela E, Littell R, Oliva E, Seiden M, Krasner C, Lee H, Fuller A
published in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
information resource reference: Extent of extracranial disease is a powerful predictor of survival in patients with brain metastases from gynecological cancer. Int J Gynecol Cancer. 2008 Mar-Apr; 18(2):262-8.
journal title abbreviation: Int J Gynecol Cancer
publication date: 2007-06-22T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Patient-reported outcomes in relapsed ovarian cancer: results from a randomized Phase III study of trabectedin with pegylated liposomal doxorubicin (PLD) versus PLD alone.
PubMed Identifier: 22765965
author list: Krasner CN, Poveda A, Herzog TJ, Vermorken JB, Kaye SB, Nieto A, Claret PL, Park YC, Parekh T, Monk BJ
published in: Gynecologic oncology
information resource reference: Patient-reported outcomes in relapsed ovarian cancer: results from a randomized Phase III study of trabectedin with pegylated liposomal doxorubicin (PLD) versus PLD alone. Gynecol Oncol. 2012 Oct; 127(1):161-7.
journal title abbreviation: Gynecol Oncol
publication date: 2012-07-02T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

Trabectedin as single agent in relapsed advanced ovarian cancer: results from a retrospective pooled analysis of three phase II trials.
PubMed Identifier: 23397080
author list: del Campo JM, Sessa C, Krasner CN, Vermorken JB, Colombo N, Kaye S, Gore M, Zintl P, Gómez J, Parekh T, Park YC, McMeekin S
published in: Medical oncology (Northwood, London, England)
information resource reference: Trabectedin as single agent in relapsed advanced ovarian cancer: results from a retrospective pooled analysis of three phase II trials. Med Oncol. 2013 Mar; 30(1):435.
journal title abbreviation: Med Oncol
publication date: 2013-02-09T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1131956
type: Authorship
author rank in publication: 1
linked author: Krasner, Carolyn
linked information resource: Final report on serial phase II trials of all-intraperitoneal chemotherapy with or without bevacizumab for women with newly diagnosed, optimally cytoreduced carcinoma of Müllerian origin.

Final report on serial phase II trials of all-intraperitoneal chemotherapy with or without bevacizumab for women with newly diagnosed, optimally cytoreduced carcinoma of Müllerian origin.
PubMed Identifier: 30765148
author list: Krasner CN, Castro C, Penson RT, Roche M, Matulonis UA, Morgan MA, Drescher C, Armstrong DK, Wolfe JK, Lee H, Supko JG, Seiden M, Birrer MJ, Dizon DS
published in: Gynecologic oncology
information resource reference: Final report on serial phase II trials of all-intraperitoneal chemotherapy with or without bevacizumab for women with newly diagnosed, optimally cytoreduced carcinoma of Müllerian origin. Gynecol Oncol. 2019 05; 153(2):223-229.
journal title abbreviation: Gynecol Oncol
publication date: 2019-02-12T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1139598
type: Authorship
author rank in publication: 3
linked author: Krasner, Carolyn
linked information resource: A tumor board report of an 83-year-old woman with stage IB grade 3 endometrioid endometrial adenocarcinoma.

A tumor board report of an 83-year-old woman with stage IB grade 3 endometrioid endometrial adenocarcinoma.
PubMed Identifier: 30770127
author list: Alimena S, Fiascone S, Krasner C, King M, Horowitz N
published in: Current problems in cancer
information resource reference: A tumor board report of an 83-year-old woman with stage IB grade 3 endometrioid endometrial adenocarcinoma. Curr Probl Cancer. 2019 10; 43(5):443-449.
journal title abbreviation: Curr Probl Cancer
publication date: 2019-02-07T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Ovarian Neoplasms
MeSH DescriptorUI: D010051
MeSH semantic group name: Disorders
number of authors: 1143
number of publications: 5183
uniqueness weight: 0.294153
type: Concept

Antineoplastic Combined Chemotherapy Protocols
MeSH DescriptorUI: D000971
MeSH semantic group name: Procedures
number of authors: 1827
number of publications: 12490
uniqueness weight: 0.217478
type: Concept

Peritoneal Neoplasms
MeSH DescriptorUI: D010534
MeSH semantic group name: Disorders
number of authors: 293
number of publications: 739
uniqueness weight: 0.613766
type: Concept

Fallopian Tube Neoplasms
MeSH DescriptorUI: D005185
MeSH semantic group name: Disorders
number of authors: 101
number of publications: 343
uniqueness weight: 0.789396
type: Concept

Authorship 1171
type: Authorship
author rank in publication: 4
linked author: Krasner, Carolyn
linked information resource: Trabectedin plus pegylated liposomal Doxorubicin in recurrent ovarian cancer.

Endometrial Neoplasms
MeSH DescriptorUI: D016889
MeSH semantic group name: Disorders
number of authors: 421
number of publications: 1498
uniqueness weight: 0.485561
type: Concept

Medicine
type: Department
type: Organization

Obstetrics Gynecology & Repro. Bio.
type: Department
type: Organization

Pathology
type: Department
type: Organization

Hematology/Oncology
type: Division
type: Organization

Adult Oncology
type: Division
type: Organization

Oncology
type: Division
type: Organization

Brigham and Women's Hospital
type: Organization

Dana-Farber Cancer Institute
type: Organization

Massachusetts General Hospital
type: Organization

Konstantinopoulos, Panagiotis
eCommons Login: PK39
first name: Panagiotis
last name: Konstantinopoulos
full name: Panagiotis Konstantinopoulos, M.D., Ph.D.
has faculty rank: Full Professor
latitude: 42.34022770000000
longitude: -71.10585400000000
Person ID: 55714
person in primary position: Professor of Medicine
type: Agent
type: Person
preferred title: Professor of Medicine

Barbie, David
eCommons Login: DAB12
first name: David
last name: Barbie
full name: David Allen Barbie, M.D.
has faculty rank: Full Professor
latitude: 42.36241700000000
longitude: -71.06893700000000
Person ID: 85733
person in primary position: Professor of Medicine
type: Agent
type: Person
preferred title: Professor of Medicine

Richardson, Paul
eCommons Login: PGR1
first name: Paul
last name: Richardson
full name: Paul Gerard Guy Richardson, M.B.,B.S.
has faculty rank: Full Professor
latitude: 42.33789600000000
longitude: -71.10724930000000
Person ID: 65832
person in primary position: R.J. Corman Professor of Medicine
type: Agent
type: Person
preferred title: R.J. Corman Professor of Medicine

Horowitz, Neil
eCommons Login: NSH6
first name: Neil
last name: Horowitz
full name: Neil Stuart Horowitz, M.D.
has faculty rank: Associate Professor
latitude: 42.33510370000000
longitude: -71.10616490000000
Person ID: 72267
person in primary position: Associate Professor of Obstetrics, Gynecology and Reproductive Biology
type: Agent
type: Person
preferred title: Associate Professor of Obstetrics, Gynecology and Reproductive Biology

Matulonis, Ursula
eCommons Login: UAM1
first name: Ursula
last name: Matulonis
full name: Ursula Anne Matulonis, M.D.
has faculty rank: Full Professor
latitude: 42.33789600000000
longitude: -71.10724930000000
Person ID: 87439
person in primary position: Professor of Medicine
type: Agent
type: Person
preferred title: Professor of Medicine

Iyasere, Christiana
eCommons Login: CI2
first name: Christiana
last name: Iyasere
full name: Christiana Adesua Iyasere, M.D.
has faculty rank: Assistant Professor
latitude: 42.36241700000000
longitude: -71.06893700000000
Person ID: 37663
person in primary position: Assistant Professor of Medicine
type: Agent
type: Person
preferred title: Assistant Professor of Medicine

Campos, Susana
eCommons Login: SMC1
first name: Susana
last name: Campos
full name: Susana Maria Campos, M.D.
has faculty rank: Assistant Professor
latitude: 42.33789600000000
longitude: -71.10724930000000
Person ID: 47389
person in primary position: Assistant Professor of Medicine
type: Agent
type: Person
preferred title: Assistant Professor of Medicine

Oliva, Esther
eCommons Login: EO1
first name: Esther
last name: Oliva
full name: Esther Oliva, M.D.
has faculty rank: Full Professor
latitude: 42.36241700000000
longitude: -71.06893700000000
Person ID: 55720
person in primary position: Professor of Pathology
type: Agent
type: Person
preferred title: Professor of Pathology

Murakami, Mark
eCommons Login: MAM77
first name: Mark
last name: Murakami
full name: Mark Alan Murakami, M.D.
has faculty rank: Assistant Professor
latitude: 42.36241700000000
longitude: -71.06893700000000
Person ID: 84833
person in primary position: Assistant Professor of Medicine
type: Agent
type: Person
preferred title: Assistant Professor of Medicine

Penson, Richard
eCommons Login: RTP3
first name: Richard
last name: Penson
full name: Richard Thomas Penson, M.B.,B.S.
has faculty rank: Associate Professor
latitude: 42.36389900000000
longitude: -71.06777800000000
Person ID: 40002
person in primary position: Associate Professor of Medicine
type: Agent
type: Person
preferred title: Associate Professor of Medicine

Tolaney, Sara
eCommons Login: SMT9
first name: Sara
last name: Tolaney
full name: Sara Michell Tolaney, M.D.
has faculty rank: Associate Professor
latitude: 42.33789600000000
longitude: -71.10724930000000
Person ID: 67909
person in primary position: Associate Professor of Medicine
type: Agent
type: Person
preferred title: Associate Professor of Medicine

Shaw, Alice
eCommons Login: APT1
first name: Alice
last name: Shaw
full name: Alice Tsang Shaw, M.D., Ph.D.
has faculty rank: Full Professor
latitude: 42.36241700000000
longitude: -71.06893700000000
Person ID: 7296
person in primary position: George P. Canellos, MD, and Jean S. Canellos Professor of Medicine Professor of Medicine
type: Agent
type: Person
preferred title: George P. Canellos, MD, and Jean S. Canellos Professor of Medicine Professor of Medicine

Bychkovsky, Brittany
eCommons Login: BLL4
first name: Brittany
last name: Bychkovsky
full name: Brittany Louise Bychkovsky, M.D.
has faculty rank: Assistant Professor
latitude: 42.36241700000000
longitude: -71.06893700000000
Person ID: 84835
person in primary position: Assistant Professor of Medicine
type: Agent
type: Person
preferred title: Assistant Professor of Medicine

selected publications
maximum weight: 1
minimum weight: 1
number of connections: 87
predicate node: https://connects.catalyst.harvard.edu/Profiles/profile/113
predicate: selected publications
type: Network

research areas
maximum weight: 1.44806
minimum weight: 0.0014479
number of connections: 230
predicate node: https://connects.catalyst.harvard.edu/Profiles/profile/217
predicate: research areas
type: Network

coauthor of
maximum weight: 3.35478
minimum weight: 0.0123113
number of connections: 55
predicate node: https://connects.catalyst.harvard.edu/Profiles/profile/363
predicate: coauthor of
type: Network

similar to
maximum weight: 65.4565
minimum weight: 8.50115
number of connections: 60
predicate node: https://connects.catalyst.harvard.edu/Profiles/profile/494
predicate: similar to
type: Network

Authorship 1186043
type: Authorship
author rank in publication: 5
linked author: Krasner, Carolyn
linked information resource: Phase II Study of Avelumab in Patients With Mismatch Repair Deficient and Mismatch Repair Proficient Recurrent/Persistent Endometrial Cancer.

Phase II Study of Avelumab in Patients With Mismatch Repair Deficient and Mismatch Repair Proficient Recurrent/Persistent Endometrial Cancer.
PubMed Identifier: 31461377
author list: Konstantinopoulos PA, Luo W, Liu JF, Gulhan DC, Krasner C, Ishizuka JJ, Gockley AA, Buss M, Growdon WB, Crowe H, Campos S, Lindeman NI, Hill S, Stover E, Schumer S, Wright AA, Curtis J, Quinn R, Whalen C, Gray KP, Penson RT, Cannistra SA, Fleming GF, Matulonis UA
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Phase II Study of Avelumab in Patients With Mismatch Repair Deficient and Mismatch Repair Proficient Recurrent/Persistent Endometrial Cancer. J Clin Oncol. 2019 10 20; 37(30):2786-2794.
journal title abbreviation: J Clin Oncol
publication date: 2019-08-28T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Professor of Pathology
is primary position: true
position in department: Pathology
position in division: https://connects.catalyst.harvard.edu/Profiles/profile/1229413
sort order: 1
type: Position
HR job title: Professor of Pathology
position in organization: Massachusetts General Hospital

Professor of Medicine
is primary position: true
position in department: Medicine
position in division: Adult Oncology
sort order: 1
type: Position
HR job title: Professor of Medicine
position in organization: Dana-Farber Cancer Institute

Assistant Professor of Medicine
is primary position: true
position in department: Medicine
position in division: Oncology
sort order: 1
type: Position
HR job title: Assistant Professor of Medicine
position in organization: Dana-Farber Cancer Institute

R.J. Corman Professor of Medicine
is primary position: true
position in department: Medicine
position in division: Oncology
sort order: 1
type: Position
HR job title: R.J. Corman Professor of Medicine
position in organization: Dana-Farber Cancer Institute

Authorship 15940
type: Authorship
author rank in publication: 5
linked author: Krasner, Carolyn
linked information resource: Phase II study of carboplatin, paclitaxel, and bevacizumab with maintenance bevacizumab as first-line chemotherapy for advanced mullerian tumors.

Authorship 180328
type: Authorship
author rank in publication: 4
linked author: Krasner, Carolyn
linked information resource: Long-acting octreotide for the treatment and symptomatic relief of bowel obstruction in advanced ovarian cancer.

Authorship 188422
type: Authorship
author rank in publication: 1
linked author: Krasner, Carolyn
linked information resource: Zevalin: 90yttrium labeled anti-CD20 (ibritumomab tiuxetan), a new treatment for non-Hodgkin's lymphoma.

Associate Professor of Obstetrics, Gynecology and Reproductive Biology
is primary position: true
position in department: Obstetrics Gynecology & Repro. Bio.
position in division: https://connects.catalyst.harvard.edu/Profiles/profile/1229413
sort order: 1
type: Position
HR job title: Associate Professor of Obstetrics, Gynecology and Reproductive Biology
position in organization: Brigham and Women's Hospital

Combined pembrolizumab and pegylated liposomal doxorubicin in platinum resistant ovarian cancer: A phase 2 clinical trial.
PubMed Identifier: 32771276
author list: Lee EK, Xiong N, Cheng SC, Barry WT, Penson RT, Konstantinopoulos PA, Hoffman MA, Horowitz N, Dizon DS, Stover EH, Wright AA, Campos SM, Krasner C, Morrissey S, Whalen C, Quinn R, Matulonis UA, Liu JF
published in: Gynecologic oncology
information resource reference: Combined pembrolizumab and pegylated liposomal doxorubicin in platinum resistant ovarian cancer: A phase 2 clinical trial. Gynecol Oncol. 2020 10; 159(1):72-78.
journal title abbreviation: Gynecol Oncol
publication date: 2020-08-06T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1276495
type: Authorship
author rank in publication: 13
linked author: Krasner, Carolyn
linked information resource: Combined pembrolizumab and pegylated liposomal doxorubicin in platinum resistant ovarian cancer: A phase 2 clinical trial.

Associate Professor of Medicine
is primary position: true
position in department: Medicine
position in division: Oncology
sort order: 1
type: Position
HR job title: Associate Professor of Medicine
position in organization: Dana-Farber Cancer Institute

Authorship 1317341
type: Authorship
author rank in publication: 2
linked author: Krasner, Carolyn
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/174160963

https://connects.catalyst.harvard.edu/Profiles/profile/174160963
PubMed Identifier: 33390325
author list: Duska LR, Krasner CN, O'Malley DM, Hays JL, Modesitt SC, Mathews CA, Moore KN, Thaker PH, Miller A, Purdy C, Zamboni WC, Lucas AT, Supko JG, Schilder RJ
published in: Gynecologic oncology
information resource reference: A phase Ib/II and pharmacokinetic study of EP0057 (formerly CRLX101) in combination with weekly paclitaxel in patients with recurrent or persistent epithelial ovarian, fallopian tube, or primary peritoneal cancer. Gynecol Oncol. 2021 03; 160(3):688-695.
journal title abbreviation: Gynecol Oncol
publication date: 2020-12-31T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource
label: A phase Ib/II and pharmacokinetic study of EP0057 (formerly CRLX101) in combination with weekly paclitaxel in patients with recurrent or persistent epithelial ovarian, fallopian tube, or primary peritoneal cancer.

Authorship 1334136
type: Authorship
author rank in publication: 7
linked author: Krasner, Carolyn
linked information resource: Stepping into survivorship pilot study: Harnessing mobile health and principles of behavioral economics to increase physical activity in ovarian cancer survivors.

Stepping into survivorship pilot study: Harnessing mobile health and principles of behavioral economics to increase physical activity in ovarian cancer survivors.
PubMed Identifier: 33637350
author list: Schrier E, Xiong N, Thompson E, Poort H, Schumer S, Liu JF, Krasner C, Campos SM, Horowitz NS, Feltmate C, Konstantinopoulos PA, Dinardo MM, Tayob N, Matulonis UA, Patel M, Wright AA
published in: Gynecologic oncology
information resource reference: Stepping into survivorship pilot study: Harnessing mobile health and principles of behavioral economics to increase physical activity in ovarian cancer survivors. Gynecol Oncol. 2021 05; 161(2):581-586.
journal title abbreviation: Gynecol Oncol
publication date: 2021-02-23T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1337812
type: Authorship
author rank in publication: 5
linked author: Krasner, Carolyn
linked information resource: Phase II Study of the WEE1 Inhibitor Adavosertib in Recurrent Uterine Serous Carcinoma.

Phase II Study of the WEE1 Inhibitor Adavosertib in Recurrent Uterine Serous Carcinoma.
PubMed Identifier: 33705205
author list: Liu JF, Xiong N, Campos SM, Wright AA, Krasner C, Schumer S, Horowitz N, Veneris J, Tayob N, Morrissey S, West G, Quinn R, Matulonis UA, Konstantinopoulos PA
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Phase II Study of the WEE1 Inhibitor Adavosertib in Recurrent Uterine Serous Carcinoma. J Clin Oncol. 2021 05 10; 39(14):1531-1539.
journal title abbreviation: J Clin Oncol
publication date: 2021-03-11T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1373558
type: Authorship
author rank in publication: 1
linked author: Krasner, Carolyn
linked information resource: Sequential Phase II clinical trials evaluating CRLX101 as monotherapy and in combination with bevacizumab in recurrent ovarian cancer.

Sequential Phase II clinical trials evaluating CRLX101 as monotherapy and in combination with bevacizumab in recurrent ovarian cancer.
PubMed Identifier: 34243976
author list: Krasner CN, Campos SM, Young CL, Chadda KR, Lee H, Birrer MJ, Horowitz NS, Konstantinopoulos PA, D'Ascanio AM, Matulonis UA, Penson RT
published in: Gynecologic oncology
information resource reference: Sequential Phase II clinical trials evaluating CRLX101 as monotherapy and in combination with bevacizumab in recurrent ovarian cancer. Gynecol Oncol. 2021 09; 162(3):661-666.
journal title abbreviation: Gynecol Oncol
publication date: 2021-07-07T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1429608
type: Authorship
author rank in publication: 3
linked author: Krasner, Carolyn
linked information resource: A phase I study of AZD2171 and Temsirolimus in patients with advanced gynecological malignancies.

A phase I study of AZD2171 and Temsirolimus in patients with advanced gynecological malignancies.
PubMed Identifier: 35142863
author list: Campos SM, Berlin S, Krasner CN, Whalen C, Atkinson T, Meegan K, Pereira L, Tyburski K, Lou W, Lee H, Horowitz N, Penson RT
published in: Cancer chemotherapy and pharmacology
information resource reference: A phase I study of AZD2171 and Temsirolimus in patients with advanced gynecological malignancies. Cancer Chemother Pharmacol. 2022 03; 89(3):423-430.
journal title abbreviation: Cancer Chemother Pharmacol
publication date: 2022-02-10T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1463029
type: Authorship
author rank in publication: 4
linked author: Krasner, Carolyn
linked information resource: Evaluation of Treatment With Talazoparib and Avelumab in Patients With Recurrent Mismatch Repair Proficient Endometrial Cancer.

Evaluation of Treatment With Talazoparib and Avelumab in Patients With Recurrent Mismatch Repair Proficient Endometrial Cancer.
PubMed Identifier: 35900726
author list: Konstantinopoulos PA, Gockley AA, Xiong N, Krasner C, Horowitz N, Campos S, Wright AA, Liu JF, Shea M, Yeku O, Castro C, Polak M, Lee EK, Sawyer H, Bowes B, Moroney J, Cheng SC, Tayob N, Bouberhan S, Spriggs D, Penson RT, Fleming GF, Nucci MR, Matulonis UA
published in: JAMA oncology
information resource reference: Evaluation of Treatment With Talazoparib and Avelumab in Patients With Recurrent Mismatch Repair Proficient Endometrial Cancer. JAMA Oncol. 2022 09 01; 8(9):1317-1322.
journal title abbreviation: JAMA Oncol
publication date: 2022-09-01T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1500275
type: Authorship
author rank in publication: 6
linked author: Krasner, Carolyn
linked information resource: A randomized phase II trial of bevacizumab vs. bevacizumab and erlotinib as first-line consolidation after carboplatin, paclitaxel, and bevacizumab in newly diagnosed patients with mullerian tumors.

Authorship 1500726
type: Authorship
author rank in publication: 4
linked author: Krasner, Carolyn
linked information resource: A Phase II, Two-Stage Study of Letrozole and Abemaciclib in Estrogen Receptor-Positive Recurrent Endometrial Cancer.

A randomized phase II trial of bevacizumab vs. bevacizumab and erlotinib as first-line consolidation after carboplatin, paclitaxel, and bevacizumab in newly diagnosed patients with mullerian tumors.
PubMed Identifier: 36344654
author list: Campos S, Matulonis U, Berlin S, Horowitz N, Liu J, Krasner C, Hang L, Zarwan C, Barry W, Colella T, Whalen C, Shoni M, Lundquist C, Birrer MJ, Penson R
published in: International journal of clinical oncology
information resource reference: A randomized phase II trial of bevacizumab vs. bevacizumab and erlotinib as first-line consolidation after carboplatin, paclitaxel, and bevacizumab in newly diagnosed patients with mullerian tumors. Int J Clin Oncol. 2022 Dec; 27(12):1881-1890.
journal title abbreviation: Int J Clin Oncol
publication date: 2022-11-08T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

A Phase II, Two-Stage Study of Letrozole and Abemaciclib in Estrogen Receptor-Positive Recurrent Endometrial Cancer.
PubMed Identifier: 36174113
author list: Konstantinopoulos PA, Lee EK, Xiong N, Krasner C, Campos S, Kolin DL, Liu JF, Horowitz N, Wright AA, Bouberhan S, Penson RT, Yeku O, Bowes B, Needham H, Hayes M, Sawyer H, Polak M, Shea M, Cheng SC, Castro C, Matulonis UA
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: A Phase II, Two-Stage Study of Letrozole and Abemaciclib in Estrogen Receptor-Positive Recurrent Endometrial Cancer. J Clin Oncol. 2023 01 20; 41(3):599-608.
journal title abbreviation: J Clin Oncol
publication date: 2022-09-29T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1521552
type: Authorship
author rank in publication: 4
linked author: Krasner, Carolyn
linked information resource: Phase II Trials of Iniparib (BSI-201) in Combination with Gemcitabine and Carboplatin in Patients with Recurrent Ovarian Cancer.

Phase II Trials of Iniparib (BSI-201) in Combination with Gemcitabine and Carboplatin in Patients with Recurrent Ovarian Cancer.
PubMed Identifier: 36718018
author list: Penson RT, Ambrosio AJ, Whalen CA, Krasner CN, Konstantinopoulos PA, Bradley C, Matulonis UA, Birrer MJ
published in: The oncologist
information resource reference: Phase II Trials of Iniparib (BSI-201) in Combination with Gemcitabine and Carboplatin in Patients with Recurrent Ovarian Cancer. Oncologist. 2023 03 17; 28(3):252-257.
journal title abbreviation: Oncologist
publication date: 2023-03-17T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Kidney function in patients with ovarian cancer treated with poly (ADP-ribose) polymerase (PARP) inhibitors.
PubMed Identifier: 37074956
author list: Gupta S, Hanna PE, Ouyang T, Yamada KS, Sawtell R, Wang Q, Katz-Agranov N, Feghali L, Krasner CN, Bouberhan S, Castro CM, Sise ME
published in: Journal of the National Cancer Institute
information resource reference: Kidney function in patients with ovarian cancer treated with poly (ADP-ribose) polymerase (PARP) inhibitors. J Natl Cancer Inst. 2023 07 06; 115(7):831-837.
journal title abbreviation: J Natl Cancer Inst
publication date: 2023-07-06T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1563795
type: Authorship
author rank in publication: 9
linked author: Krasner, Carolyn
linked information resource: Kidney function in patients with ovarian cancer treated with poly (ADP-ribose) polymerase (PARP) inhibitors.

Authorship 223696
type: Authorship
author rank in publication: 6
linked author: Krasner, Carolyn
linked information resource: Phase II study of carboplatin and pemetrexed for the treatment of platinum-sensitive recurrent ovarian cancer.

Assistant Professor of Medicine
is primary position: true
position in department: Medicine
position in division: Oncology
sort order: 1
type: Position
HR job title: Assistant Professor of Medicine
position in organization: Dana-Farber Cancer Institute

Authorship 548582
type: Authorship
author rank in publication: 3
linked author: Krasner, Carolyn
linked information resource: Phase II evaluation of pemetrexed in the treatment of recurrent or persistent platinum-resistant ovarian or primary peritoneal carcinoma: a study of the Gynecologic Oncology Group.

Authorship 1630316
type: Authorship
author rank in publication: 3
linked author: Krasner, Carolyn
linked information resource: Combined aromatase, CDK4/6 and PI3K blockade using letrozole/abemaciclib/LY3023414 in endometrial cancer.

Combined aromatase, CDK4/6 and PI3K blockade using letrozole/abemaciclib/LY3023414 in endometrial cancer.
PubMed Identifier: 38425459
author list: Konstantinopoulos PA, Xiong N, Krasner C, Liu JF, Sawyer H, Polak M, Needham H, Geddes M, Koppermann L, Shea M, Castro C, Cheng SC, Matulonis UA, Lee EK
published in: Gynecologic oncology reports
information resource reference: Combined aromatase, CDK4/6 and PI3K blockade using letrozole/abemaciclib/LY3023414 in endometrial cancer. Gynecol Oncol Rep. 2024 Apr; 52:101348.
journal title abbreviation: Gynecol Oncol Rep
publication date: 2024-02-22T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 303829
type: Authorship
author rank in publication: 5
linked author: Krasner, Carolyn
linked information resource: Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management.

Authorship 1659054
type: Authorship
author rank in publication: 10
linked author: Krasner, Carolyn
linked information resource: Feasibility and acceptability of a nurse-led telehealth intervention (BOLSTER) to support patients with peritoneal carcinomatosis and their caregivers: A pilot randomized clinical trial.

Feasibility and acceptability of a nurse-led telehealth intervention (BOLSTER) to support patients with peritoneal carcinomatosis and their caregivers: A pilot randomized clinical trial.
PubMed Identifier: 38851039
author list: Pozzar RA, Enzinger AC, Howard C, Tavormina A, Matulonis UA, Campos S, Liu JF, Horowitz N, Konstantinopoulos PA, Krasner C, Wall JA, Sciacca K, Meyer LA, Lindvall C, Wright AA
published in: Gynecologic oncology
information resource reference: Feasibility and acceptability of a nurse-led telehealth intervention (BOLSTER) to support patients with peritoneal carcinomatosis and their caregivers: A pilot randomized clinical trial. Gynecol Oncol. 2024 Sep; 188:1-7.
journal title abbreviation: Gynecol Oncol
publication date: 2024-06-07T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Associate Professor of Medicine
is primary position: true
position in department: Medicine
position in division: Hematology/Oncology
sort order: 1
type: Position
HR job title: Associate Professor of Medicine
position in organization: Massachusetts General Hospital

Assistant Professor of Medicine
is primary position: true
position in department: Medicine
position in division: Oncology
sort order: 1
type: Position
HR job title: Assistant Professor of Medicine
position in organization: Dana-Farber Cancer Institute

Authorship 241919
type: Authorship
author rank in publication: 5
linked author: Krasner, Carolyn
linked information resource: Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer.

Authorship 664315
type: Authorship
author rank in publication: 2
linked author: Krasner, Carolyn
linked information resource: Phase II study of weekly PM00104 (ZALYPSIS(®)) in patients with pretreated advanced/metastatic endometrial or cervical cancer.

Phase II study of weekly PM00104 (ZALYPSIS(®)) in patients with pretreated advanced/metastatic endometrial or cervical cancer.
PubMed Identifier: 23771800
author list: Martin LP, Krasner C, Rutledge T, Ibañes ML, Fernández-García EM, Kahatt C, Gómez MS, McMeekin S
published in: Medical oncology (Northwood, London, England)
information resource reference: Phase II study of weekly PM00104 (ZALYPSIS(®)) in patients with pretreated advanced/metastatic endometrial or cervical cancer. Med Oncol. 2013; 30(3):627.
journal title abbreviation: Med Oncol
publication date: 2013-06-15T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 571298
type: Authorship
author rank in publication: 1
linked author: Krasner, Carolyn
linked information resource: Case records of the Massachusetts General Hospital. Case 11-2006. A 54-year-old woman with a mass in the pelvis.

Authorship 675063
type: Authorship
author rank in publication: 7
linked author: Krasner, Carolyn
linked information resource: Patterns of recurrence in patients treated with bevacizumab in the primary treatment of advanced epithelial ovarian cancer.

Patterns of recurrence in patients treated with bevacizumab in the primary treatment of advanced epithelial ovarian cancer.
PubMed Identifier: 23975042
author list: Rauh-Hain JA, Guseh SH, Esselen KM, Growdon WB, Schorge JO, Horowitz NS, Krasner CN, del Carmen MG, Birrer MJ, Dizon DS
published in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
information resource reference: Patterns of recurrence in patients treated with bevacizumab in the primary treatment of advanced epithelial ovarian cancer. Int J Gynecol Cancer. 2013 Sep; 23(7):1219-25.
journal title abbreviation: Int J Gynecol Cancer
publication date: 2013-09-01T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

Professor of Medicine
is primary position: true
position in department: Medicine
position in division: Oncology
sort order: 1
type: Position
HR job title: Professor of Medicine
position in organization: Dana-Farber Cancer Institute

Authorship 1740135
type: Authorship
author rank in publication: 4
linked author: Krasner, Carolyn
linked information resource: Serial Circulating Tumor DNA Sequencing to Monitor Response and Define Acquired Resistance to Letrozole/Abemaciclib in Endometrial Cancer.

Serial Circulating Tumor DNA Sequencing to Monitor Response and Define Acquired Resistance to Letrozole/Abemaciclib in Endometrial Cancer.
PubMed Identifier: 40209137
author list: Konstantinopoulos PA, Cai M, Lee EK, Krasner C, Campos SM, Liu JF, Horowitz NS, Shea M, Parsons HA, Wright AA, Bouberhan S, Penson RT, Yeku O, Hayes M, Sawyer H, Polak M, Castro CM, Cheng SC, Weipert CM, Matulonis UA
published in: JCO precision oncology
information resource reference: Serial Circulating Tumor DNA Sequencing to Monitor Response and Define Acquired Resistance to Letrozole/Abemaciclib in Endometrial Cancer. JCO Precis Oncol. 2025 Apr; 9:e2400882.
journal title abbreviation: JCO Precis Oncol
publication date: 2025-04-10T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1752791
type: Authorship
author rank in publication: 3
linked author: Krasner, Carolyn
linked information resource: Phase 2, two-stage study of avelumab and axitinib in patients with mismatch repair proficient recurrent or persistent endometrial cancer.

Phase 2, two-stage study of avelumab and axitinib in patients with mismatch repair proficient recurrent or persistent endometrial cancer.
PubMed Identifier: 40393272
author list: Lee EK, Xiong N, Krasner C, Polak M, Campos S, Wright AA, Liu JF, Shea M, Yeku O, Castro C, Porter R, Stover EH, Koppermann L, Smith J, Sawyer H, Hayes M, Zhou N, Cheng SC, Bouberhan S, Pfaff KL, Rodig SJ, Jones S, Penson RT, Moroney J, Fleming GF, Matulonis UA, Konstantinopoulos PA
published in: Gynecologic oncology
information resource reference: Phase 2, two-stage study of avelumab and axitinib in patients with mismatch repair proficient recurrent or persistent endometrial cancer. Gynecol Oncol. 2025 Jul; 198:1-8.
journal title abbreviation: Gynecol Oncol
publication date: 2025-05-20T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 21270
type: Authorship
author rank in publication: 4
linked author: Krasner, Carolyn
linked information resource: Low-molecular-weight heparin (dalteparin) in women with gynecologic malignancy.

Authorship 224486
type: Authorship
author rank in publication: 5
linked author: Krasner, Carolyn
linked information resource: Phase II trial of erlotinib in women with squamous cell carcinoma of the vulva.

Instructor in Medicine
is primary position: true
position in department: Medicine
position in division: Oncology
sort order: 1
type: Position
HR job title: Instructor in Medicine
position in organization: Dana-Farber Cancer Institute

Authorship 288780
type: Authorship
author rank in publication: 4
linked author: Krasner, Carolyn
linked information resource: Phase I/II dose finding study of combination cisplatin and gemcitabine in patients with recurrent cervix cancer.

Professor of Medicine
is primary position: true
position in department: Medicine
position in division: Oncology
sort order: 1
type: Position
HR job title: Professor of Medicine
position in organization: Dana-Farber Cancer Institute

Authorship 714899
type: Authorship
author rank in publication: 13
linked author: Krasner, Carolyn
linked information resource: Phase 2 trial of aromatase inhibition with letrozole in patients with uterine leiomyosarcomas expressing estrogen and/or progesterone receptors.

Phase 2 trial of aromatase inhibition with letrozole in patients with uterine leiomyosarcomas expressing estrogen and/or progesterone receptors.
PubMed Identifier: 24222211
author list: George S, Feng Y, Manola J, Nucci MR, Butrynski JE, Morgan JA, Ramaiya N, Quek R, Penson RT, Wagner AJ, Harmon D, Demetri GD, Krasner C
published in: Cancer
information resource reference: Phase 2 trial of aromatase inhibition with letrozole in patients with uterine leiomyosarcomas expressing estrogen and/or progesterone receptors. Cancer. 2014 Mar 01; 120(5):738-43.
journal title abbreviation: Cancer
publication date: 2013-11-12T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 250157
type: Authorship
author rank in publication: 3
linked author: Krasner, Carolyn
linked information resource: Trabectedin as single agent in relapsed advanced ovarian cancer: results from a retrospective pooled analysis of three phase II trials.

George P. Canellos, MD, and Jean S. Canellos Professor of Medicine Professor of Medicine
is primary position: true
position in department: Medicine
position in division: Oncology
sort order: 1
type: Position
HR job title: George P. Canellos, MD, and Jean S. Canellos Professor of Medicine Professor of Medicine
position in organization: Dana-Farber Cancer Institute

Authorship 1794140
type: Authorship
author rank in publication: 6
linked author: Krasner, Carolyn
linked information resource: Letrozole, abemaciclib and metformin in endometrial cancer: a non-randomized phase 2 trial.

Authorship 1825055
type: Authorship
author rank in publication: 4
linked author: Krasner, Carolyn
linked information resource: Phase 2 study of Wee1 inhibitor adavosertib in recurrent uterine carcinosarcoma.

Phase 2 study of Wee1 inhibitor adavosertib in recurrent uterine carcinosarcoma.
PubMed Identifier: 40678577
author list: Cham S, Xiong N, Tayob N, Krasner C, Wright AA, Lee EK, Sawyer H, Mathews C, Konstantinopoulos PA, Matulonis UA, Liu JF
published in: Gynecologic oncology reports
information resource reference: Phase 2 study of Wee1 inhibitor adavosertib in recurrent uterine carcinosarcoma. Gynecol Oncol Rep. 2025 Aug; 60:101796.
journal title abbreviation: Gynecol Oncol Rep
publication date: 2025-06-24T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Letrozole, abemaciclib and metformin in endometrial cancer: a non-randomized phase 2 trial.
PubMed Identifier: 41339350
author list: Konstantinopoulos PA, Zhou N, Penson RT, Le TV, Campos S, Krasner C, Wright AA, Porter R, Horowitz N, Bouberhan S, Liu JF, Hindenach S, Sawyer H, Koppermann L, Hayes M, Polak M, Shea M, Widick P, Cheng SC, Castro C, Beumer JH, Matulonis UA, Lee EK
published in: Nature communications
information resource reference: Letrozole, abemaciclib and metformin in endometrial cancer: a non-randomized phase 2 trial. Nat Commun. 2025 Dec 03; 17(1):395.
journal title abbreviation: Nat Commun
publication date: 2025-12-03T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Assistant Professor of Medicine
is primary position: true
position in department: Medicine
position in division: Oncology
sort order: 1
type: Position
HR job title: Assistant Professor of Medicine
position in organization: Dana-Farber Cancer Institute

Authorship 348633
type: Authorship
author rank in publication: 3
linked author: Krasner, Carolyn
linked information resource: Advanced small cell carcinoma of the ovary in a seventeen-year-old female, successfully treated with surgery and multi-agent chemotherapy.

Authorship 414993
type: Authorship
author rank in publication: 3
linked author: Krasner, Carolyn
linked information resource: Phase II trial of GM-CSF in women with asymptomatic recurrent müllerian tumors.

Authorship 765434
type: Authorship
author rank in publication: 14
linked author: Krasner, Carolyn
linked information resource: Catumaxomab for the treatment of malignant ascites in patients with chemotherapy-refractory ovarian cancer: a phase II study.

Authorship 767323
type: Authorship
author rank in publication: 3
linked author: Krasner, Carolyn
linked information resource: Urinary catheter in laparoscopic cholecystectomy: is it necessary?

Authorship 766581
type: Authorship
author rank in publication: 2
linked author: Krasner, Carolyn
linked information resource: Moraxella catarrhalis bacteremia as a cause of erythema nodosum.

Moraxella catarrhalis bacteremia as a cause of erythema nodosum.
PubMed Identifier: 8879804
author list: Periyakoil V, Krasner C
published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
information resource reference: Moraxella catarrhalis bacteremia as a cause of erythema nodosum. Clin Infect Dis. 1996 Sep; 23(3):650-1.
journal title abbreviation: Clin Infect Dis
publication date: 1996-09-01T00:00:00
year: 1996
type: Academic Article
type: Article
type: Document
type: Information Resource

Catumaxomab for the treatment of malignant ascites in patients with chemotherapy-refractory ovarian cancer: a phase II study.
PubMed Identifier: 25254563
author list: Berek JS, Edwards RP, Parker LP, DeMars LR, Herzog TJ, Lentz SS, Morris RT, Akerley WL, Holloway RW, Method MW, Plaxe SC, Walker JL, Friccius-Quecke H, Krasner CN
published in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
information resource reference: Catumaxomab for the treatment of malignant ascites in patients with chemotherapy-refractory ovarian cancer: a phase II study. Int J Gynecol Cancer. 2014 Nov; 24(9):1583-9.
journal title abbreviation: Int J Gynecol Cancer
publication date: 2014-11-01T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource

Urinary catheter in laparoscopic cholecystectomy: is it necessary?
PubMed Identifier: 10803996
author list: Liu SK, Rassai H, Krasner C, Braun J, Matolo NM
published in: Surgical laparoscopy, endoscopy & percutaneous techniques
information resource reference: Urinary catheter in laparoscopic cholecystectomy: is it necessary? Surg Laparosc Endosc Percutan Tech. 1999 Jun; 9(3):184-6.
journal title abbreviation: Surg Laparosc Endosc Percutan Tech
publication date: 1999-06-01T00:00:00
year: 1999
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 399957
type: Authorship
author rank in publication: 1
linked author: Krasner, Carolyn
linked information resource: Patient-reported outcomes in relapsed ovarian cancer: results from a randomized Phase III study of trabectedin with pegylated liposomal doxorubicin (PLD) versus PLD alone.

Authorship 229002
type: Authorship
author rank in publication: 11
linked author: Krasner, Carolyn
linked information resource: Phase I trial of liposomal doxorubicin and ZD1839 in patients with refractory gynecological malignancies or metastatic breast cancer.

Authorship 377875
type: Authorship
author rank in publication: 3
linked author: Krasner, Carolyn
linked information resource: Treatment of uterine papillary serous carcinoma with platinum-based chemotherapy and paclitaxel.

Authorship 295745
type: Authorship
author rank in publication: 4
linked author: Krasner, Carolyn
linked information resource: A phase II study of fixed dose rate gemcitabine in patients with relapsed müllerian tumors.

Authorship 323478
type: Authorship
author rank in publication: 7
linked author: Krasner, Carolyn
linked information resource: Phase I trial of escalating doses of topotecan in combination with a fixed dose of pegylated liposomal doxorubicin in women with müllerian malignancies.

Authorship 284877
type: Authorship
author rank in publication: 1
linked author: Krasner, Carolyn
linked information resource: A Phase II study of trabectedin single agent in patients with recurrent ovarian cancer previously treated with platinum-based regimens.

Authorship 311448
type: Authorship
author rank in publication: 4
linked author: Krasner, Carolyn
linked information resource: Patterns of recurrence in advanced epithelial ovarian, fallopian tube and peritoneal cancers treated with intraperitoneal chemotherapy.

Authorship 234178
type: Authorship
author rank in publication: 4
linked author: Krasner, Carolyn
linked information resource: Trabectedin plus pegylated liposomal doxorubicin (PLD) versus PLD in recurrent ovarian cancer: overall survival analysis.

Authorship 232985
type: Authorship
author rank in publication: 2
linked author: Krasner, Carolyn
linked information resource: Detection of Staphylococcus aureus in peripheral blood stem cell cultures after sterilization of standard blood cultures.

Authorship 263833
type: Authorship
author rank in publication: 5
linked author: Krasner, Carolyn
linked information resource: Cediranib, an oral inhibitor of vascular endothelial growth factor receptor kinases, is an active drug in recurrent epithelial ovarian, fallopian tube, and peritoneal cancer.

Authorship 234465
type: Authorship
author rank in publication: 7
linked author: Krasner, Carolyn
linked information resource: A phase II evaluation of pemetrexed (Alimta, LY231514, IND #40061) in the treatment of recurrent or persistent endometrial carcinoma: a phase II study of the Gynecologic Oncology.

Authorship 241468
type: Authorship
author rank in publication: 1
linked author: Krasner, Carolyn
linked information resource: Aromatase inhibitors in gynecologic cancers.

Authorship 31281
type: Authorship
author rank in publication: 5
linked author: Krasner, Carolyn
linked information resource: A phase II trial of weekly docetaxel in patients with platinum-resistant epithelial ovarian, primary peritoneal serous cancer, or fallopian tube cancer.

Authorship 334696
type: Authorship
linked author: Krasner, Carolyn
linked information resource: Erratum: Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer.

Authorship 435625
type: Authorship
author rank in publication: 3
linked author: Krasner, Carolyn
linked information resource: Three sequential chemotherapy doublets for the treatment of newly diagnosed advanced müllerian malignancies: the modified triple doublet regimen.

Authorship 46107
type: Authorship
author rank in publication: 3
linked author: Krasner, Carolyn
linked information resource: Treatment of squamous cell vulvar cancer with the anti-EGFR tyrosine kinase inhibitor Tarceva.

Authorship 799639
type: Authorship
author rank in publication: 11
linked author: Krasner, Carolyn
linked information resource: Translational impact of nanoparticle-drug conjugate CRLX101 with or without bevacizumab in advanced ovarian cancer.

Translational impact of nanoparticle-drug conjugate CRLX101 with or without bevacizumab in advanced ovarian cancer.
PubMed Identifier: 25524310
author list: Pham E, Birrer MJ, Eliasof S, Garmey EG, Lazarus D, Lee CR, Man S, Matulonis UA, Peters CG, Xu P, Krasner C, Kerbel RS
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Translational impact of nanoparticle-drug conjugate CRLX101 with or without bevacizumab in advanced ovarian cancer. Clin Cancer Res. 2015 Feb 15; 21(4):808-18.
journal title abbreviation: Clin Cancer Res
publication date: 2014-12-18T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 819342
type: Authorship
author rank in publication: 9
linked author: Krasner, Carolyn
linked information resource: Phase I study of combination of vorinostat, carboplatin, and gemcitabine in women with recurrent, platinum-sensitive epithelial ovarian, fallopian tube, or peritoneal cancer.

Phase I study of combination of vorinostat, carboplatin, and gemcitabine in women with recurrent, platinum-sensitive epithelial ovarian, fallopian tube, or peritoneal cancer.
PubMed Identifier: 26119093
author list: Matulonis U, Berlin S, Lee H, Whalen C, Obermayer E, Penson R, Liu J, Campos S, Krasner C, Horowitz N
published in: Cancer chemotherapy and pharmacology
information resource reference: Phase I study of combination of vorinostat, carboplatin, and gemcitabine in women with recurrent, platinum-sensitive epithelial ovarian, fallopian tube, or peritoneal cancer. Cancer Chemother Pharmacol. 2015 Aug; 76(2):417-23.
journal title abbreviation: Cancer Chemother Pharmacol
publication date: 2015-06-29T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 431064
type: Authorship
author rank in publication: 3
linked author: Krasner, Carolyn
linked information resource: Phase II prospective study of paclitaxel and carboplatin in older patients with newly diagnosed Müllerian tumors.

Authorship 875718
type: Authorship
author rank in publication: 5
linked author: Krasner, Carolyn
linked information resource: A SNaPshot of potentially personalized care: Molecular diagnostics in gynecologic cancer.

A SNaPshot of potentially personalized care: Molecular diagnostics in gynecologic cancer.
PubMed Identifier: 27016236
author list: Penson RT, Sales E, Sullivan L, Borger DR, Krasner CN, Goodman AK, del Carmen MG, Growdon WB, Schorge JO, Boruta DM, Castro CM, Dizon DS, Birrer MJ
published in: Gynecologic oncology
information resource reference: A SNaPshot of potentially personalized care: Molecular diagnostics in gynecologic cancer. Gynecol Oncol. 2016 Apr; 141(1):108-12.
journal title abbreviation: Gynecol Oncol
publication date: 2016-04-01T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Assistant Professor
sort order: 2
type: Faculty Rank

Associate Professor
sort order: 1
type: Faculty Rank

Full Professor
sort order: 0
type: Faculty Rank

Instructor
sort order: 4
type: Faculty Rank

Authorship 361068
type: Authorship
author rank in publication: 1
linked author: Krasner, Carolyn
linked information resource: Management of women with newly diagnosed ovarian cancer.

Authorship 926250
type: Authorship
author rank in publication: 9
linked author: Krasner, Carolyn
linked information resource: Safety, Efficacy, and Biomarker Exploration in a Phase II Study of Bevacizumab, Oxaliplatin, and Gemcitabine in Recurrent Müllerian Carcinoma.

Authorship 925933
type: Authorship
author rank in publication: 7
linked author: Krasner, Carolyn
linked information resource: Phase 1 and 2 study of carboplatin and pralatrexate in patients with recurrent, platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer.

Phase 1 and 2 study of carboplatin and pralatrexate in patients with recurrent, platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer.
PubMed Identifier: 27421044
author list: Del Carmen MG, Supko JG, Horick NK, Rauh-Hain JA, Clark RM, Campos SM, Krasner CN, Atkinson T, Birrer MJ
published in: Cancer
information resource reference: Phase 1 and 2 study of carboplatin and pralatrexate in patients with recurrent, platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer. Cancer. 2016 Nov 15; 122(21):3297-3306.
journal title abbreviation: Cancer
publication date: 2016-07-15T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 239364
type: Authorship
author rank in publication: 6
linked author: Krasner, Carolyn
linked information resource: Extent of extracranial disease is a powerful predictor of survival in patients with brain metastases from gynecological cancer.

Authorship 943784
type: Authorship
author rank in publication: 3
linked author: Krasner, Carolyn
linked information resource: A phase II evaluation of pemetrexed (ALIMTA, LY231514, IND#40061) in the treatment of recurrent or persistent endometrial carcinoma: A phase II study of the Gynecologic Oncology Group.

Authorship 941836
type: Authorship
author rank in publication: 1
linked author: Krasner, Carolyn
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/71516816

Authorship 941986
type: Authorship
author rank in publication: 3
linked author: Krasner, Carolyn
linked information resource: Phase II trial of GM-CSF in women with asymptomatic müllerian cancer.

Authorship 942847
type: Authorship
author rank in publication: 4
linked author: Krasner, Carolyn
linked information resource: Phase II study of carboplatin, paclitaxel and bevacizumab as first line chemotherapy and consolidation for advanced müllerian tumors.

Authorship 941982
type: Authorship
author rank in publication: 1
linked author: Krasner, Carolyn
linked information resource: Pharmacokinetic analysis of an all intraperitoneal carboplatin and paclitaxel regimen in ovarian cancer patients demonstrates favorable systemic bioavailability of both agents.

Authorship 942036
type: Authorship
author rank in publication: 9
linked author: Krasner, Carolyn
linked information resource: Phase I trial of liposomal doxorubicin and ZD 1839 in patients with refractory gynecological malignancies or metastatic breast cancer.

Pharmacokinetic analysis of an all intraperitoneal carboplatin and paclitaxel regimen in ovarian cancer patients demonstrates favorable systemic bioavailability of both agents.
PubMed Identifier: 27952185
author list: Krasner CN, Seiden MV, Fuller AF, Roche M, Verrill CL, D'Amato F, Tretyakov O, Tyburski K, Matulonis UA, Supko JG
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Pharmacokinetic analysis of an all intraperitoneal carboplatin and paclitaxel regimen in ovarian cancer patients demonstrates favorable systemic bioavailability of both agents. J Clin Oncol. 2006 Jun 20; 24(18_suppl):5008.
journal title abbreviation: J Clin Oncol
publication date: 2006-06-20T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

Phase II trial of GM-CSF in women with asymptomatic müllerian cancer.
PubMed Identifier: 27952385
author list: Roche M, Matulonis U, Krasner C, Penson R, Horowitz N, Berkenblit A, Findley M, Lee J, Horick N, Seiden MV
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Phase II trial of GM-CSF in women with asymptomatic müllerian cancer. J Clin Oncol. 2006 Jun 20; 24(18_suppl):5081.
journal title abbreviation: J Clin Oncol
publication date: 2006-06-20T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

Phase II study of carboplatin, paclitaxel and bevacizumab as first line chemotherapy and consolidation for advanced müllerian tumors.
PubMed Identifier: 27952190
author list: Penson RT, Cannistra SA, Seiden MV, Krasner CN, Matulonis UA, Horowitz NS, Berlin S, Dizon DS, Lee H, Campos SM
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Phase II study of carboplatin, paclitaxel and bevacizumab as first line chemotherapy and consolidation for advanced müllerian tumors. J Clin Oncol. 2006 Jun 20; 24(18_suppl):5020.
journal title abbreviation: J Clin Oncol
publication date: 2006-06-20T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

A phase II evaluation of pemetrexed (ALIMTA, LY231514, IND#40061) in the treatment of recurrent or persistent endometrial carcinoma: A phase II study of the Gynecologic Oncology Group.
PubMed Identifier: 27960769
author list: Miller DS, Blessing JA, Krasner CN, Drake RD, Higgins R, McMeekin DS, Puneky LV
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: A phase II evaluation of pemetrexed (ALIMTA, LY231514, IND#40061) in the treatment of recurrent or persistent endometrial carcinoma: A phase II study of the Gynecologic Oncology Group. J Clin Oncol. 2009 May 20; 27(15_suppl):e16507.
journal title abbreviation: J Clin Oncol
publication date: 2009-05-20T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Phase I trial of liposomal doxorubicin and ZD 1839 in patients with refractory gynecological malignancies or metastatic breast cancer.
PubMed Identifier: 27952379
author list: Campos SM, Parker L, Chen W, Bunnell CA, Atkinson T, Lee J, Matulonis UA, Harris LN, Krasner CN
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Phase I trial of liposomal doxorubicin and ZD 1839 in patients with refractory gynecological malignancies or metastatic breast cancer. J Clin Oncol. 2006 Jun 20; 24(18_suppl):5085.
journal title abbreviation: J Clin Oncol
publication date: 2006-06-20T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

https://connects.catalyst.harvard.edu/Profiles/profile/71516816
PubMed Identifier: 27962478
author list: Krasner CN, Poveda A, Herzog T, Vermorken J, Monk B, Zintl P, Li J, Su Y, Dhawan R, Kaye S
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Health-related quality of life/patient-reported outcomes in relapsed ovarian cancer: Results from a randomized phase III study of trabectedin with pegylated liposomal doxorubicin (PLD) versus PLD alone. J Clin Oncol. 2009 May 20; 27(15_suppl):5526.
journal title abbreviation: J Clin Oncol
publication date: 2009-05-20T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Health-related quality of life/patient-reported outcomes in relapsed ovarian cancer: Results from a randomized phase III study of trabectedin with pegylated liposomal doxorubicin (PLD) versus PLD alone.

Authorship 944892
type: Authorship
author rank in publication: 2
linked author: Krasner, Carolyn
linked information resource: Long-acting octreotide for the treatment of symptoms of bowel obstruction and intermittent obstruction in advanced ovarian cancer.

Authorship 944777
type: Authorship
author rank in publication: 4
linked author: Krasner, Carolyn
linked information resource: A phase II trial of iniparib (BSI-201) in combination with gemcitabine/carboplatin (GC) in patients with platinum-sensitive recurrent ovarian cancer.

Authorship 945388
type: Authorship
author rank in publication: 1
linked author: Krasner, Carolyn
linked information resource: A phase II study of weekly trabectedin (ET-743) in second/third line ovarian carcinoma.

Authorship 945638
type: Authorship
author rank in publication: 15
linked author: Krasner, Carolyn
linked information resource: Catumaxomab treatment of malignant ascites in patients with chemotherapy-refractory ovarian cancer: A phase II study.

Authorship 945510
type: Authorship
author rank in publication: 4
linked author: Krasner, Carolyn
linked information resource: A phase II study of fixed dose-rate gemcitabine in patients with relapsed Müllerian tumors.

Authorship 946033
type: Authorship
author rank in publication: 4
linked author: Krasner, Carolyn
linked information resource: Final survival results of the randomized phase III study of trabectedin with pegylated liposomal doxorubicin (PLD) versus PLD in recurrent ovarian cancer.

A phase II study of weekly trabectedin (ET-743) in second/third line ovarian carcinoma.
PubMed Identifier: 28015535
author list: Krasner CN, McMeekin S, Chan S, Braly P, Kaye S, Provencher D, Klecz J, Michiels B, Van de Velde H, Gore M
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: A phase II study of weekly trabectedin (ET-743) in second/third line ovarian carcinoma. J Clin Oncol. 2004 Jul 15; 22(14_suppl):5045.
journal title abbreviation: J Clin Oncol
publication date: 2004-07-15T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

Final survival results of the randomized phase III study of trabectedin with pegylated liposomal doxorubicin (PLD) versus PLD in recurrent ovarian cancer.
PubMed Identifier: 28023701
author list: Monk BJ, Herzog TJ, Kaye SB, Krasner CN, Vermorken JB, Muggia F, Pujade-Lourraine E, Zintl P, Parekh TV, Poveda A
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Final survival results of the randomized phase III study of trabectedin with pegylated liposomal doxorubicin (PLD) versus PLD in recurrent ovarian cancer. J Clin Oncol. 2011 May 20; 29(15_suppl):5046.
journal title abbreviation: J Clin Oncol
publication date: 2011-05-20T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

A phase II study of fixed dose-rate gemcitabine in patients with relapsed Müllerian tumors.
PubMed Identifier: 28016790
author list: Penson RT, Seiden MV, Campos SM, Krasner CN, Fuller AF, Goodman A, Roche M, Willman A, Muzikansky A, Matulonis UA
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: A phase II study of fixed dose-rate gemcitabine in patients with relapsed Müllerian tumors. J Clin Oncol. 2004 Jul 15; 22(14_suppl):5151.
journal title abbreviation: J Clin Oncol
publication date: 2004-07-15T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

Long-acting octreotide for the treatment of symptoms of bowel obstruction and intermittent obstruction in advanced ovarian cancer.
PubMed Identifier: 28016806
author list: Matulonis U, Krasner C, Atkinson T, Penson R
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Long-acting octreotide for the treatment of symptoms of bowel obstruction and intermittent obstruction in advanced ovarian cancer. J Clin Oncol. 2004 Jul 15; 22(14_suppl):5148.
journal title abbreviation: J Clin Oncol
publication date: 2004-07-15T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

A phase II trial of iniparib (BSI-201) in combination with gemcitabine/carboplatin (GC) in patients with platinum-sensitive recurrent ovarian cancer.
PubMed Identifier: 28023776
author list: Penson RT, Whalen C, Lasonde B, Krasner CN, Konstantinopoulos P, Stallings TE, Bradley CR, Birrer MJ, Matulonis U
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: A phase II trial of iniparib (BSI-201) in combination with gemcitabine/carboplatin (GC) in patients with platinum-sensitive recurrent ovarian cancer. J Clin Oncol. 2011 May 20; 29(15_suppl):5004.
journal title abbreviation: J Clin Oncol
publication date: 2011-05-20T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Catumaxomab treatment of malignant ascites in patients with chemotherapy-refractory ovarian cancer: A phase II study.
PubMed Identifier: 28023703
author list: Berek JS, Edwards RP, Parker L, DeMars LR, Herzog TJ, Lentz SS, Morris R, Akerley WL, Holloway RW, Method M, Plaxe SC, Walker JL, Schindler T, Schulze E, Krasner CN
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Catumaxomab treatment of malignant ascites in patients with chemotherapy-refractory ovarian cancer: A phase II study. J Clin Oncol. 2011 May 20; 29(15_suppl):5048.
journal title abbreviation: J Clin Oncol
publication date: 2011-05-20T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 949874
type: Authorship
author rank in publication: 7
linked author: Krasner, Carolyn
linked information resource: Extended carboplatin infusion does not reduce frequency of hypersensitivity reaction at initiation of retreatment in patients with recurrent platinum-sensitive ovarian cancer.

Extended carboplatin infusion does not reduce frequency of hypersensitivity reaction at initiation of retreatment in patients with recurrent platinum-sensitive ovarian cancer.
PubMed Identifier: 27641482
author list: Lax T, Dizon DS, Birrer M, Long A, Del Carmen M, Goodman A, Krasner C, Penson RT, Growdon W, Camargo CA, Banerji A
published in: The journal of allergy and clinical immunology. In practice
information resource reference: Extended carboplatin infusion does not reduce frequency of hypersensitivity reaction at initiation of retreatment in patients with recurrent platinum-sensitive ovarian cancer. J Allergy Clin Immunol Pract. 2017 Jan - Feb; 5(1):177-178.
journal title abbreviation: J Allergy Clin Immunol Pract
publication date: 2016-09-15T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

450 Brookline Ave
type: Address
address line 1: Dana-Farber Cancer Institute
address line 2: Hem/Oncology
address line 3: 450 Brookline Ave
city: Boston
postal code: 02215
state or province: MA

Authorship 966304
type: Authorship
author rank in publication: 3
linked author: Krasner, Carolyn
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/76070424

Authorship 965381
type: Authorship
author rank in publication: 2
linked author: Krasner, Carolyn
linked information resource: Final results of a phase II study of weekly trabectedin in second/third line ovarian carcinoma.

Authorship 960322
type: Authorship
author rank in publication: 2
linked author: Krasner, Carolyn
linked information resource: Long-acting octreotide for the treatment of symptoms of bowel obstruction in advanced ovarian cancer.

Authorship 961119
type: Authorship
author rank in publication: 1
linked author: Krasner, Carolyn
linked information resource: Phase II trial of anastrazole in combination with gefitinib in women with asymptomatic mullerian cancer.

Authorship 964793
type: Authorship
author rank in publication: 6
linked author: Krasner, Carolyn
linked information resource: Combination carboplatin and pemetrexed for the treatment of platinum-sensitive recurrent ovarian cancer.

Authorship 966302
type: Authorship
author rank in publication: 1
linked author: Krasner, Carolyn
linked information resource: NOV-002 plus carboplatin in platinum-resistant ovarian cancer.

Authorship 965165
type: Authorship
author rank in publication: 3
linked author: Krasner, Carolyn
linked information resource: Cediranib (AZD2171) is an active agent in recurrent epithelial ovarian cancer.

Authorship 964885
type: Authorship
author rank in publication: 9
linked author: Krasner, Carolyn
linked information resource: Phase II study of carboplatin and paclitaxel in elderly women with newly diagnosed ovarian, peritoneal, or fallopian tube cancer.

Authorship 966321
type: Authorship
author rank in publication: 3
linked author: Krasner, Carolyn
linked information resource: A phase II trial of modified triple doublets for the treatment of advanced Müllerian malignancies.

https://connects.catalyst.harvard.edu/Profiles/profile/76070424
PubMed Identifier: 27950846
author list: Miller DS, Blessing JA, Krasner CN, Mannel RJ
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: A phase II evaluation of pemetrexed (LY231514, IND #40061) in the treatment of recurrent or persistent platinum-resistant ovarian or primary peritoneal carcinoma: A study of the gynecologic oncology group. J Clin Oncol. 2008 May 20; 26(15_suppl):5524.
journal title abbreviation: J Clin Oncol
publication date: 2008-05-20T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource
label: A phase II evaluation of pemetrexed (LY231514, IND #40061) in the treatment of recurrent or persistent platinum-resistant ovarian or primary peritoneal carcinoma: A study of the gynecologic oncology group.

Phase II study of carboplatin and paclitaxel in elderly women with newly diagnosed ovarian, peritoneal, or fallopian tube cancer.
PubMed Identifier: 27950420
author list: Penson RT, Kornblith AB, Lee J, Roche M, Atkinson T, Gibson CD, Horowitz NS, Krag KJ, Krasner CN, Matulonis UA
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Phase II study of carboplatin and paclitaxel in elderly women with newly diagnosed ovarian, peritoneal, or fallopian tube cancer. J Clin Oncol. 2008 May 20; 26(15_suppl):5590.
journal title abbreviation: J Clin Oncol
publication date: 2008-05-20T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Cediranib (AZD2171) is an active agent in recurrent epithelial ovarian cancer.
PubMed Identifier: 27950813
author list: Matulonis UA, Berlin ST, Krasner CN, Tyburski K, Lee J, Roche M, Ivy SP, Lenahan C, King M, Penson RT
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Cediranib (AZD2171) is an active agent in recurrent epithelial ovarian cancer. J Clin Oncol. 2008 May 20; 26(15_suppl):5501.
journal title abbreviation: J Clin Oncol
publication date: 2008-05-20T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

A phase II trial of modified triple doublets for the treatment of advanced Müllerian malignancies.
PubMed Identifier: 27946271
author list: Matulonis UA, Campos S, Krasner C, Duska L, Penson RP, Falke R, Roche M, Smith LM, Lee H, Seiden MV
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: A phase II trial of modified triple doublets for the treatment of advanced Müllerian malignancies. J Clin Oncol. 2005 Jun; 23(16_suppl):5010.
journal title abbreviation: J Clin Oncol
publication date: 2005-06-01T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

Long-acting octreotide for the treatment of symptoms of bowel obstruction in advanced ovarian cancer.
PubMed Identifier: 27946709
author list: Penson RT, Krasner CN, Seiden MV, Atkinson T, Kornblith A, Campos S, Klein A, Matulonis U
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Long-acting octreotide for the treatment of symptoms of bowel obstruction in advanced ovarian cancer. J Clin Oncol. 2005 Jun; 23(16_suppl):5159.
journal title abbreviation: J Clin Oncol
publication date: 2005-06-01T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

Combination carboplatin and pemetrexed for the treatment of platinum-sensitive recurrent ovarian cancer.
PubMed Identifier: 27950841
author list: Horowitz NS, Penson RT, Campos SM, Lee J, Kendall DL, Krasner CN, Berlin ST, Roche M, Duska LR, Matulonis UA
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Combination carboplatin and pemetrexed for the treatment of platinum-sensitive recurrent ovarian cancer. J Clin Oncol. 2008 May 20; 26(15_suppl):5523.
journal title abbreviation: J Clin Oncol
publication date: 2008-05-20T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Final results of a phase II study of weekly trabectedin in second/third line ovarian carcinoma.
PubMed Identifier: 27946277
author list: McMeekin DS, Krasner C, Chan S, Braly P, Kaye S, Provencher D, Trifan OC, Michiels B, Gore M
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Final results of a phase II study of weekly trabectedin in second/third line ovarian carcinoma. J Clin Oncol. 2005 Jun; 23(16_suppl):5011.
journal title abbreviation: J Clin Oncol
publication date: 2005-06-01T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

Phase II trial of anastrazole in combination with gefitinib in women with asymptomatic mullerian cancer.
PubMed Identifier: 27946319
author list: Krasner CN, Debernardo RL, Findley M, Penson R, Matulonis U, Atkinson T, Roche M, Seiden MV
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Phase II trial of anastrazole in combination with gefitinib in women with asymptomatic mullerian cancer. J Clin Oncol. 2005 Jun; 23(16_suppl):5063.
journal title abbreviation: J Clin Oncol
publication date: 2005-06-01T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

NOV-002 plus carboplatin in platinum-resistant ovarian cancer.
PubMed Identifier: 27950463
author list: Krasner CN, Seiden MV, Penson RT, Roche M, Kendall DL, Young J, Matulonis UA, Pereira L, Berlin ST
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: NOV-002 plus carboplatin in platinum-resistant ovarian cancer. J Clin Oncol. 2008 May 20; 26(15_suppl):5593.
journal title abbreviation: J Clin Oncol
publication date: 2008-05-20T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Erratum: Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer.
PubMed Identifier: 17525937
author list: Kornblith AB, Powell M, Regan MM, Bennett S, Krasner C, Moy B, Younger J, Goodman A, Berkowitz R, Winer E
published in: Psycho-oncology
information resource reference: Erratum: Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer. Psychooncology. 2007 May 24; 16(10).
journal title abbreviation: Psychooncology
publication date: 2007-05-24T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Phase II study of carboplatin, paclitaxel, and bevacizumab with maintenance bevacizumab as first-line chemotherapy for advanced mullerian tumors.
PubMed Identifier: 19917843
author list: Penson RT, Dizon DS, Cannistra SA, Roche MR, Krasner CN, Berlin ST, Horowitz NS, Disilvestro PA, Matulonis UA, Lee H, King MA, Campos SM
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Phase II study of carboplatin, paclitaxel, and bevacizumab with maintenance bevacizumab as first-line chemotherapy for advanced mullerian tumors. J Clin Oncol. 2010 Jan 01; 28(1):154-9.
journal title abbreviation: J Clin Oncol
publication date: 2009-11-16T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Phase I trial of escalating doses of topotecan in combination with a fixed dose of pegylated liposomal doxorubicin in women with müllerian malignancies.
PubMed Identifier: 15196868
author list: Penson RT, Seiden MV, Goodman A, Fuller AF, Berkowitz RS, Matulonis UA, Krasner C, Lee H, Atkinson T, Campos SM
published in: Gynecologic oncology
information resource reference: Phase I trial of escalating doses of topotecan in combination with a fixed dose of pegylated liposomal doxorubicin in women with müllerian malignancies. Gynecol Oncol. 2004 Jun; 93(3):702-7.
journal title abbreviation: Gynecol Oncol
publication date: 2004-06-01T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

Advanced small cell carcinoma of the ovary in a seventeen-year-old female, successfully treated with surgery and multi-agent chemotherapy.
PubMed Identifier: 17914739
author list: Kanwar VS, Heath J, Krasner CN, Pearce JM
published in: Pediatric blood & cancer
information resource reference: Advanced small cell carcinoma of the ovary in a seventeen-year-old female, successfully treated with surgery and multi-agent chemotherapy. Pediatr Blood Cancer. 2008 May; 50(5):1060-2.
journal title abbreviation: Pediatr Blood Cancer
publication date: 2008-05-01T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Detection of Staphylococcus aureus in peripheral blood stem cell cultures after sterilization of standard blood cultures.
PubMed Identifier: 12717792
author list: Schwaber MJ, Krasner CN, Gold HS, Venkataraman L, Avigan DE, Karchmer AW, Uhl L
published in: Journal of clinical apheresis
information resource reference: Detection of Staphylococcus aureus in peripheral blood stem cell cultures after sterilization of standard blood cultures. J Clin Apher. 2003; 18(1):37-9.
journal title abbreviation: J Clin Apher
publication date: 2003-01-01T00:00:00
year: 2003
type: Academic Article
type: Article
type: Document
type: Information Resource

Treatment of squamous cell vulvar cancer with the anti-EGFR tyrosine kinase inhibitor Tarceva.
PubMed Identifier: 17561233
author list: Olawaiye A, Lee LM, Krasner C, Horowitz N
published in: Gynecologic oncology
information resource reference: Treatment of squamous cell vulvar cancer with the anti-EGFR tyrosine kinase inhibitor Tarceva. Gynecol Oncol. 2007 Sep; 106(3):628-30.
journal title abbreviation: Gynecol Oncol
publication date: 2007-06-11T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer.
PubMed Identifier: 17245695
author list: Kornblith AB, Powell M, Regan MM, Bennett S, Krasner C, Moy B, Younger J, Goodman A, Berkowitz R, Winer E
published in: Psycho-oncology
information resource reference: Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer. Psychooncology. 2007 Oct; 16(10):895-903.
journal title abbreviation: Psychooncology
publication date: 2007-10-01T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Case records of the Massachusetts General Hospital. Case 11-2006. A 54-year-old woman with a mass in the pelvis.
PubMed Identifier: 16611953
author list: Krasner CN, Roche M, Horowitz NS, Supko JG, Lee SI, Oliva E
published in: The New England journal of medicine
information resource reference: Case records of the Massachusetts General Hospital. Case 11-2006. A 54-year-old woman with a mass in the pelvis. N Engl J Med. 2006 Apr 13; 354(15):1615-25.
journal title abbreviation: N Engl J Med
publication date: 2006-04-13T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

Aromatase inhibitors in gynecologic cancers.
PubMed Identifier: 17826626
author list: Krasner C
published in: The Journal of steroid biochemistry and molecular biology
information resource reference: Aromatase inhibitors in gynecologic cancers. J Steroid Biochem Mol Biol. 2007 Aug-Sep; 106(1-5):76-80.
journal title abbreviation: J Steroid Biochem Mol Biol
publication date: 2007-05-24T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Safety, Efficacy, and Biomarker Exploration in a Phase II Study of Bevacizumab, Oxaliplatin, and Gemcitabine in Recurrent Müllerian Carcinoma.
PubMed Identifier: 21833345
author list: Horowitz NS, Penson RT, Duda DG, di Tomaso E, Boucher Y, Ancukiewicz M, Cohen KS, Berlin S, Krasner CN, Moses MA, Jain RK
published in: Clinical ovarian cancer and other gynecologic malignancies
information resource reference: Safety, Efficacy, and Biomarker Exploration in a Phase II Study of Bevacizumab, Oxaliplatin, and Gemcitabine in Recurrent Müllerian Carcinoma. Clin Ovarian Cancer Other Gynecol Malig. 2011 Jun; 4(1):26-33.
journal title abbreviation: Clin Ovarian Cancer Other Gynecol Malig
publication date: 2011-06-01T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Treatment of uterine papillary serous carcinoma with platinum-based chemotherapy and paclitaxel.
PubMed Identifier: 16515602
author list: Vaidya AP, Littell R, Krasner C, Duska LR
published in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
information resource reference: Treatment of uterine papillary serous carcinoma with platinum-based chemotherapy and paclitaxel. Int J Gynecol Cancer. 2006 Jan-Feb; 16 Suppl 1:267-72.
journal title abbreviation: Int J Gynecol Cancer
publication date: 2006-01-01T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

Phase I/II dose finding study of combination cisplatin and gemcitabine in patients with recurrent cervix cancer.
PubMed Identifier: 16566993
author list: Matulonis UA, Campos S, Duska L, Krasner CN, Atkinson T, Penson RT, Seiden MV, Verrill C, Fuller AF, Goodman A
published in: Gynecologic oncology
information resource reference: Phase I/II dose finding study of combination cisplatin and gemcitabine in patients with recurrent cervix cancer. Gynecol Oncol. 2006 Oct; 103(1):160-4.
journal title abbreviation: Gynecol Oncol
publication date: 2006-03-29T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

Phase II evaluation of pemetrexed in the treatment of recurrent or persistent platinum-resistant ovarian or primary peritoneal carcinoma: a study of the Gynecologic Oncology Group.
PubMed Identifier: 19332726
author list: Miller DS, Blessing JA, Krasner CN, Mannel RS, Hanjani P, Pearl ML, Waggoner SE, Boardman CH
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Phase II evaluation of pemetrexed in the treatment of recurrent or persistent platinum-resistant ovarian or primary peritoneal carcinoma: a study of the Gynecologic Oncology Group. J Clin Oncol. 2009 Jun 01; 27(16):2686-91.
journal title abbreviation: J Clin Oncol
publication date: 2009-03-30T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

A Phase II study of trabectedin single agent in patients with recurrent ovarian cancer previously treated with platinum-based regimens.
PubMed Identifier: 18000504
author list: Krasner CN, McMeekin DS, Chan S, Braly PS, Renshaw FG, Kaye S, Provencher DM, Campos S, Gore ME
published in: British journal of cancer
information resource reference: A Phase II study of trabectedin single agent in patients with recurrent ovarian cancer previously treated with platinum-based regimens. Br J Cancer. 2007 Dec 17; 97(12):1618-24.
journal title abbreviation: Br J Cancer
publication date: 2007-11-13T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Phase II prospective study of paclitaxel and carboplatin in older patients with newly diagnosed Müllerian tumors.
PubMed Identifier: 19058838
author list: Matulonis UA, Krag KJ, Krasner CN, Atkinson T, Horowitz NS, Lee H, Penson RT
published in: Gynecologic oncology
information resource reference: Phase II prospective study of paclitaxel and carboplatin in older patients with newly diagnosed Müllerian tumors. Gynecol Oncol. 2009 Feb; 112(2):394-9.
journal title abbreviation: Gynecol Oncol
publication date: 2008-12-05T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Cediranib, an oral inhibitor of vascular endothelial growth factor receptor kinases, is an active drug in recurrent epithelial ovarian, fallopian tube, and peritoneal cancer.
PubMed Identifier: 19826113
author list: Matulonis UA, Berlin S, Ivy P, Tyburski K, Krasner C, Zarwan C, Berkenblit A, Campos S, Horowitz N, Cannistra SA, Lee H, Lee J, Roche M, Hill M, Whalen C, Sullivan L, Tran C, Humphreys BD, Penson RT
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Cediranib, an oral inhibitor of vascular endothelial growth factor receptor kinases, is an active drug in recurrent epithelial ovarian, fallopian tube, and peritoneal cancer. J Clin Oncol. 2009 Nov 20; 27(33):5601-6.
journal title abbreviation: J Clin Oncol
publication date: 2009-10-13T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

A phase II evaluation of pemetrexed (Alimta, LY231514, IND #40061) in the treatment of recurrent or persistent endometrial carcinoma: a phase II study of the Gynecologic Oncology.
PubMed Identifier: 19804902
author list: Miller DS, Blessing JA, Drake RD, Higgins R, McMeekin DS, Puneky LV, Krasner CN
published in: Gynecologic oncology
information resource reference: A phase II evaluation of pemetrexed (Alimta, LY231514, IND #40061) in the treatment of recurrent or persistent endometrial carcinoma: a phase II study of the Gynecologic Oncology. Gynecol Oncol. 2009 Dec; 115(3):443-6.
journal title abbreviation: Gynecol Oncol
publication date: 2009-10-04T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Phase II trial of erlotinib in women with squamous cell carcinoma of the vulva.
PubMed Identifier: 22750258
author list: Horowitz NS, Olawaiye AB, Borger DR, Growdon WB, Krasner CN, Matulonis UA, Liu JF, Lee J, Brard L, Dizon DS
published in: Gynecologic oncology
information resource reference: Phase II trial of erlotinib in women with squamous cell carcinoma of the vulva. Gynecol Oncol. 2012 Oct; 127(1):141-6.
journal title abbreviation: Gynecol Oncol
publication date: 2012-06-26T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

Long-acting octreotide for the treatment and symptomatic relief of bowel obstruction in advanced ovarian cancer.
PubMed Identifier: 16376743
author list: Matulonis UA, Seiden MV, Roche M, Krasner C, Fuller AF, Atkinson T, Kornblith A, Penson R
published in: Journal of pain and symptom management
information resource reference: Long-acting octreotide for the treatment and symptomatic relief of bowel obstruction in advanced ovarian cancer. J Pain Symptom Manage. 2005 Dec; 30(6):563-9.
journal title abbreviation: J Pain Symptom Manage
publication date: 2005-12-01T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource